Early postoperative management of lung transplantation

Minerva Anestesiologica

Volumn 80, Issue 11, 2014, Pages 1234-1245

  Leal, S ^a   Sacanell, J ^a   Riera, J ^a   Masclans, J R ^a,b   Rello, J ^a,b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Antibiotics; Immunosuppression; Lung transplantion

Indexed keywords

BASILIXIMAB; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; RAPAMYCIN; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRAFT REJECTION; ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; CHRONIC PATIENT; DIAPHRAGM PARALYSIS; EARLY DIAGNOSIS; EXTRACORPOREAL OXYGENATION; GASTROESOPHAGEAL REFLUX; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; INFECTIOUS COMPLICATION; LUNG ARTERY PRESSURE; LUNG TRANSPLANTATION; MYOPATHY; NOTE; PHRENIC NERVE PARALYSIS; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; PRIMARY GRAFT DYSFUNCTION; STOMACH PARESIS; POSTOPERATIVE COMPLICATIONS; PROCEDURES;

GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG TRANSPLANTATION; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS;

EID: 84929409117     PISSN: 03759393     EISSN: 18271596     Source Type: Journal    
DOI: None     Document Type: Note

References (72)

1. Hardy JD, Webb WR, Dalton Jr. Lung homotransplantation in man. JAMA 1963;186:1065-74.
2. Christie JD, Edwards LB, Kucheryavata AY. The registry of International Society for Heart and Lung transplantation: Twenty-seventh official adult lung and heart-lung transplant report-2010. J Heart Lung transplant 2010;29:1104-18.
3. Kugler C, Fisher S, Gottlieb J. Health-related quality of life in two hundred-eighty transplant recipients. J Heart Lung transplant 2005;24:2262-8.
4. Bhorade S, Chan K, Levine D. Lung transplant considerations for the community pulmonologist. ACCP transplant network. Chest 2007 [Home]. Available from: www.chest-net.org/networks
5. Levine SM. A survey of clinical practice of lung transplantation in North America. Chest 2004;125:1224-38.
6. Masclans JR, Vicente R, Ballesteros MA. Solid organ transplant training objectives for residents. Med Intensiva 2012;36:584-8.
7. Kaplan JD, Trulock EP, Cooper JD. Pulmonary vascular permeability after lung transplantation. A positron emission tomographic study. Am Rev Respir Dis 1992;145:954-7.
8. Kundu S, Herman SJ, Winton TL. Reperfusion edema after lung transplantation: radiographic manifestations. Radiology 1998;206:75-80.
9. Pilcher DV, Scheinkestel CD, Snell GI. High central venous pressure is assoaciate with prolonged mechanical ventilation and increase mortality after lung transplantation. J Thorac Cardiovasc Surg 2005;129:912-8.
10. Hess D. Approaches to conventional mechanical ventilation of the patient with acute respiratory distress syndrome. Respir Care 2011;56:1555-72.
11. Harris R. Pressure-volume curves of respiratory system. Respir Care 2005;50:78-98.
12. Lau CL, Patterson GA, Palmer SM. Critical care aspects of lung transplantation. J intensive Care Med 2004;19:83-104.
13. Nielsen TD, Bahnson T, Davis RD. Atrial fibrillation after pulmonary transplant. Chest 2004;126:496-500.
14. Takemoto SK: Zeevi, A; Feng, S. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplan 2004; 4(7): 1033-41.
15. Suárez VJ, Miñambres E, Robles JC. Primary graft dysfunction after lung transplantation. Med Intensive 2012;36:506-13.
16. Christie JD, Bavaria JE, Palevsky HI. Primary graft dysfunction following lung transplantation. Chest 1998;114:51-6.
17. Christie JD, Kotloff RM, Pochettino A Clinical risk factors for primary graft dysfunction following lung transplantation. Chest 2003;124:1232-41.
18. King RC, Binns OA, Rodriguez F. Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Ann Thorac Surg 2000;69:1681-5.
19. Christie JD, Sager JS, Kimmel SE. Impact of primary graft failure on outcomes following lung transplantation. Chest 2005;127:161-5.
20. Christie JD, Carby M, Bag R. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction Part II: Definition. A consensus statement of the international society for heart and lung transplantation. J Heart Lung Transplant 2005;24:1454-9.
21. Date H, Triantafillou AN, Trulock EP. Inhaled nitric oxide reduces human lung allograft dysfunction. J Thorac Cardiovasc Surg 1996;111:913-9.
22. Kemming GI, Merkel MJ, Schallerer A. Inhaled nitric oxide for the treatment of early allograft failure after lung transplantation. Munich Lung Transplant group. Intensive Care Med 1998;24:1173-80.
23. Shargall Y, Guenther G, Ahya VN. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction Part VI. Treatment J Heart Lung Transplant 2005;24:1489-500.
24. Fisher S, Bohn D, Rycus P. Extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation: analysis of the extracorporeal life support organization (ELSO) registry. J Heart Lunt Transplant 2007;26:472-83.
25. Dahlberg PS, Prekker ME, Herrington CS. Medium-term results of extracorporeal membrane oxygenation for severe acute lung injury after lung transplantation. J Heart Lunt Transplant 2004;23:979-84.
26. Bermudez CA, Adusumilli PS, McCurry KR, Zaldonis D, Crespo MM, Pilewski JM et al. Extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation: long-tem survival. Ann Thorac Surg 2009;87:854-6.
27. Fiser SM, Kron IL; McLendon Long S. Early intervention after severe oxygenation index elevation improves survival following lung transplantation. J Heart Lunt Transplant 2001;20:631-6.
28. Glasman LR, Keenan RJ, Fabrizio MC. extracorporeal membrane oxygenation as an adjunct treatment for primary graft failure in adult lung transplant recipient. J Thorac Cardiovasc Surg 1995;110:723-7.
29. Christie JD, Edwards LB, Kucheryavata AY. The registry of International Society for Heart and Lung transplantation: twenty-eighth adult lung and heart-lung transplant report-2011. J Heart Lung Transplant 2011;30:1104-22.
30. Bhorade PJ, Stern E. Immunosuppression for lung transplantation. Proc Am Thorac 2009;15:47-53.
31. Keenan RJ, Konishi H, Kawai A. Clinical trial of tacrolimus versus cyclosporine in lung transplantation. Ann Thorac Surg 1995;60:580-4.
32. Treede H, Klepetko W, Reichenspurner H. Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocols. J Heart Lung Transplant 2001;20:511-7.
33. Zuckermann A, Reichenspurner H, Birsan T. Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial. J Thorac Cardiovasc Surg 2003;125:891-900.
34. Hachem RR, Yusen RD, Chakinala MM. A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation. J Heart Lung Transplant 2007; 26:1012-8.
35. Sarahrudi K, Carretta A, Wisser W. The value of switching from cyclosporine to tacrolimus in the treatment of refractory acute rejection and obliterative bronchiolitis after lung transplantation. Transpl Int 2002;15:24-8.
36. Bhorade SM, Jordan A, Villanueva J. Comparison of three tacrolimus-based immunosuppressive regimens in lung transplantation. Am J Transplant 2003;3:1570-5.
37. Scott LJ, McKeage K, Keam SJ, Plosker GL. Tacrolimus: a further update of its use in the management of organ transplantation. Drugs 2003;63:1247-97.
38. Swarup R, Allenspach LL, Nemeh HW. Timing of basiliximab induction and development of acute rejection in lung transplant patients. J Heart Lung Transplant 2011;30:1228-35.
39. Watkins KD, Boettger RF, Hanger KM. Use of sublingual tacrolimus in lung transplant recipients. J Heart Lung Transplant 2012;31:127-32.
40. Sehgal SN. Sirolimus: its discovery, biological properties, and mechanism of action. Transplant Proc 2003;35(3 Suppl):7S-14S.
41. King-Biggs MB, Dunitz JM, Park SJ. Airway anastomotic dehiscence associated with use of sirolimus immediately after lung transplantation. Transplantation 2003:75:1437-43.
42. Groetzner J, Kur F, Spelsberg F. Airway anastomosis complications in de novo lung transplantation with sirolimusDased immunosuppression. J Heart Lung Transplant 2004;23:632-8.
43. Martinu T, Chen DF, Palmer SM. Acute rejection and humoral sensitization in lung transplant recipients. Proc Am Thorac Soc 2009;15:54-65.
44. Martinu T, Pavlisko EN, Chen DF, Palmer SM. Acute allograft rejection: cellular and humoral processes. Clin Chest Med 2011;32:295-310.
45. De Vito Dabbs A, Hoffman LA, Iacono AT. Are symptom reports useful for differentiating between acute rejection and pulmonary infection after lung transplantation? Heart Lung 2004;33:372-80.
46. Ahmad S, Shlobin OA, Nathan SD. Pulmonary complications of lung transplantation. Chest 2011;139:402-11.
47. Tazelaar HD, Nilsson FN, Rinaldi M. The sensitivity of transbronchial biopsy for the diagnosis of acute lung rejection. J Thorac Cardiovasc Surg 1993;105:674-8.
48. Trulock EP, Ettinger NA, Brunt EM. The role of transbronchial lung biopsy in the treatment of lung transplant recipients. An analysis of 200 consecutive procedures. Chest 1992;102:1049-54.
49. Faro A, Visner G. The use of multiple transbronchial biopsies as the standard approach to evaluate lung allograft rejection. Pediatr Transplant 2004;8:322-8.
50. Fuehner T, Simon A, Dierich M. Indicators for steroid response in biopsy proven acute graft rejection after lung transplantation. Respir Med 2009; 103:1114-21.
51. Remund KF, Best M, Egan JJ. Infections relevant to lung transplantation. Proc Am Thorac Soc 2009;15:94-100.
52. rd ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2010. p. 114.
53. Pereyra F, Rubin RH. Prevention and treatment of cytomegalovirus infection in solid organ transplant recipients. Curr Opin Infect Dis 2004;17:357-61.
54. Zamora MR. Cytomegalovirus and lung transplantation. Am J Transplant 2004;4:1219-26.
55. Kotton CN, Kumar D, Caliendo AM. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation 2010;89:779-95.
56. rd Annual Interscience Conference of Antimicrobial Agents and Chemotherapy Chicago, IL, USA 2003.
57. Silveira FP, Husain S. Fungal infections in lung transplant recipients. Curr Opin Pulm Med 2008;14:211-8.
58. Husain S, Singh N. Bronchiolitis obliterans and lung transplantation: evidence for an infectious etiology. Semin Respir Infect 2002;17:310-4.
59. Monforte V, Roman A, Gavalda J. Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors. J Heart Lung Transplant 2001;20:1274-81.
60. Monforte V, Ussetti P, Gavaldà J. Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation. J Heart Lung Transplant 2010;29:523-30.
61. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008;46:327-60.
62. Santacruz JF, Mehta AC. Airway complications and management after lung transplantation: ischemia, dehiscence, and stenosis. Proc Am Thorac Soc 2009;15:79-93.
63. Thistlethwaite PA, Yung G, Kemp A. Airway stenoses after lung transplantation: incidence, management, and outcome. J Thorac Cardiovasc Surg 2008;136:1569-75.
64. De Gracia J, Culebras M, Alvarez A. Bronchoscopic balloon dilatation in the management of bronchial stenosis following lung transplantation. Respir Med 2007;101:27-33.
65. Dutau H, Cavailles A, Sakr L. A retrospective study of silicone stent placement for management of anastomotic airway complications in lung transplant recipients: short- and long-term outcomes. J Heart Lung Transplant 2010;29:658-64.
66. Ferdinande P, Bruyninckx F, Van Raemdonck D. Phrenic nerve dysfunction after heart-lung and lung transplantation. J Heart Lung Transplant 2004;23:105-9.
67. Lahon B, Morfant P, Thabut G. Early severe digestive complications after lung transplantation. Eur J Cardiothorac Surg 2001;40:1419-24.
68. Berkowitz N, Schulman LL, McGregor C. Gastroparesis after lung transplantation. Potential role in postoperative respiratory complications. Chest 1995;108:1602-7.
69. Paul S, Escareno CE, Clancy K. Gastrointestinal complications after lung transplantation. J Heart Lung Transplant 2009;28:475-9.
70. Raviv Y, D'Ovidio F, Pierre A. Prevalence of gastroparesis before and after lung transplantation and its association with lung allograft outcomes. Clin Transplant 2012;26:133-42.
71. Hermans G, De Jonghe B, Bruyninckx F. Critical illness polyneuropathy and myopathy. Critical Care 2008;12:238-46.
72. Fuehner T, Greer M, Welte T. The lung transplant patient in the ICU. Curr Opin Crit Care 2012;18:472-8.